Latest Entries
Less may be more in treating patients with bacteria in the urine
algorithm / antibiotic / Articles / Infectious diseases

Less may be more in treating patients with bacteria in the urine

By Dipali Pathak When doctors are confronted by the dilemma of patient who has bacteria in the urine but no symptoms to indicate that, they sometimes overtreat. However, an expert at Baylor College of Medicine and the Michael E. DeBakey Veterans Affairs Medical Center in Houston  and her colleagues find there are other ways to … Continue reading

Electronic algorithms help “find” patients lost in the system
algorithm / Articles / imaging / Patient safety / Process Improvement / Public Health

Electronic algorithms help “find” patients lost in the system

By Julia Parsons In an era when increasing pressures to increase clinical productivity can create data overload and when time is limited, sometimes the critical issue of telling patients about  an abnormal test can fall through the cracks. Researchers at Baylor College of Medicine and the Michael E. DeBakey Veterans Affairs Medical Center’s Center for Innovations in Quality, … Continue reading

Autophagy: Protector against lung inflammation and fibrosis
Articles / autophagy / Genetics / lungs / sepsis

Autophagy: Protector against lung inflammation and fibrosis

By Ruth SoRelle, M.P.H. When bacteria or viruses invade the body, a process called autophagy, or “self-eating,” springs into action to take the invaders to organelles called the lysosomes where they are degraded and discarded. In the lungs, the process is critical in fighting off infections. A new study from Baylor College of Medicine suggests that … Continue reading

Study links tumor recurrence to growth factor commonly used in high-risk neuroblastoma treatment
Articles / Cancer

Study links tumor recurrence to growth factor commonly used in high-risk neuroblastoma treatment

By Dana Benson A human growth factor that expands white blood cells in response to infection could be driving growth of neuroblastoma cancer stem cells that are thought responsible for disease relapse – a finding that could bring about changes in cancer treatment protocols, said researchers from Baylor College of Medicine in a new study … Continue reading